<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Early Metabolic Profile in Neonates with Maternal Intrahepatic Cholestasis of Pregnancy

dc.contributor.authorGuner Yilmaz, Bengisu
dc.contributor.authorAbali, Saygin
dc.contributor.authorMoniri, Ariorad
dc.contributor.authorKilinckaya, Umut
dc.contributor.authorAltinbas, Ekin
dc.contributor.authorAy, Beril
dc.contributor.authorKarakose, Bengisu
dc.contributor.authorSahinoglu, Yusuf
dc.contributor.authorSahinoglu, Melis
dc.contributor.authorYilmaz, Bugra
dc.contributor.authorSerteser, Mustafa
dc.contributor.authorKorkmaz, Ayse
dc.contributor.authorPata, Ozlem
dc.contributor.authorBeken, Serdar
dc.date.accessioned2026-11-05T11:02:58Z
dc.date.issued2025
dc.description.abstractBackground/Objectives: Intrahepatic cholestasis of pregnancy (ICP) is associated with adverse perinatal outcomes. However, its metabolic consequences on newborns remain inadequately characterized. This study investigated amino acid, carnitine, and acylcarnitine profiles in neonates born to mothers with ICP. Methods: This retrospective study encompassed 299 neonates born to mothers with ICP. For comparative analysis, term infants without additional complications (ICP-term, n = 150) were compared with term controls (n = 150). Capillary blood samples collected at 24-48 h of life as part of newborn screening were analyzed using LC-MS/MS for acylcarnitine and amino acid profiles. Results: The ICP cohort exhibited a high preterm delivery rate (46.2%), with maternal bile acids negatively correlating with gestational age (r = -0.266, p < 0.001). No inborn errors of metabolism were observed. Elevated levels of amino acids (alanine, leucine/isoleucine, valine, tyrosine, arginine, glycine, and ornithine) and specific acylcarnitines (C5, C5-OH, C10:1, and C18:2), along with decreased levels of amino acids (argininosuccinic acid and glutamic acid) and specific acylcarnitines (C3, C5-DC, C6-DC, C14, C14:1, C16, C16:1, and C18:1-OH), were observed in ICP-term neonates (p < 0.05). Receiver operating characteristic curve analysis identified ornithine (area under the curve [AUC] = 0.74) and leucine/isoleucine (AUC = 0.73) as strong discriminators. A multivariable model integrating multiple metabolites achieved high accuracy (AUC = 0.86 +/- 0.03). Conclusions: This first comprehensive characterization of neonatal metabolic alterations in ICP reveals amino acid metabolism, fatty acid oxidation, and mitochondrial function disruptions, suggesting fetal adaptation to a cholestatic intrauterine environment. Metabolomic profiling may improve understanding of maternal-fetal interactions and inform strategies for risk stratification and long-term monitoring.
dc.description.issue12
dc.description.pages1655
dc.description.volume12
dc.identifier.doi10.3390/children12121655
dc.identifier.issn2227-9067
dc.identifier.urihttps://doi.org/10.3390/children12121655
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10994
dc.identifier.wosWOS:001648183200001
dc.language.isoen
dc.publisherMDPI
dc.relation.hasversion10.3390/children12121655
dc.relation.ispartofCHILDREN-BASEL
dc.subjectgestational intrahepatic cholestasis
dc.subjectamino acid profile
dc.subjectcarnitine/acylcarnitine profile
dc.subjectmetabolomics
dc.subjectneonate
dc.subjectCARNITINE
dc.subjectSUPPLEMENTATION
dc.subjectPATHOGENESIS
dc.subjectDISORDERS
dc.subjectWEIGHT
dc.subjectBIRTH
dc.subjectACIDS
dc.subjectPediatrics
dc.titleEarly Metabolic Profile in Neonates with Maternal Intrahepatic Cholestasis of Pregnancy
dc.typeArticle
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.issue12
oaire.citation.volume12
person.identifier.orcid0000-0003-4902-417X
person.identifier.orcid0000-0002-5171-3532
person.identifier.orcid0009-0008-4576-8589
person.identifier.orcid0000-0001-6299-7844
person.identifier.orcid0009-0003-2591-6787
person.identifier.orcid0000-0003-4954-305X
person.identifier.ridPCT-4837-2025
person.identifier.ridJAN-7810-2023
person.identifier.ridPAU-7777-2025

Files

Collections